Timothy L. Beard

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial

Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat et al. · European Urology · 2014 · 214 citations

Medicine, Oncology, Surgery +11

<p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>

Sergio D. Bergese, Marek Brzeziński, Gregory B. Hammer et al. · Journal of Pain Research · 2019 · 72 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial

Teresa L. Kauf, Robert S. Svatek, Gilad E. Amiel et al. · The Journal of Urology · 2013 · 67 citations

Pharmacy, Pharmacoeconomics, Surgery +16

Association of surgical care practices with length of stay and use of clinical protocols after elective bowel resection: results of a national survey

Conor P. Delaney, Anthony J. Senagore, Todd M. Gerkin et al. · The American Journal of Surgery · 2010 · 41 citations

Medicine, Surgery, General Surgery +2

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials

Timothy L. Beard, Cathy Michalsky, Keith Candiotti et al. · Pain and Therapy · 2020 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17